A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab')2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice

Antibodies for prevention and treatment of respiratory syncytial virus infections in children

(2012) Bessey Geevarghese et al.   ANTIVIRAL THERAPY

Application of TaqMan Low-Density Arrays for Simultaneous Detection of Multiple Respiratory Pathogens

(2011) Maja Kodani et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Selective stimulation of IL-4 receptor on smooth muscle induces airway hyperresponsiveness in mice

(2011) Charles Perkins et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Respiratory Syncytial Virus Glycoprotein G Interacts with DC-SIGN and L-SIGN To Activate ERK1 and ERK2

(2011) T. R. Johnson et al.   JOURNAL OF VIROLOGY

Differential Pathogenesis of Respiratory Syncytial Virus Clinical Isolates in BALB/c Mice

(2011) K. L. Stokes et al.   JOURNAL OF VIROLOGY

Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years

(2011) Peter L. Collins et al.   VIRUS RESEARCH

MARCKS-related peptide modulates in vivo the secretion of airway Muc5ac

(2010) W. Michael Foster et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation

(2010) Steven D. Douglas et al.   Annals of the New York Academy of Sciences

Pharmacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus

(2010) Kerry M. Empey et al.   CLINICAL INFECTIOUS DISEASES

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

(2010) Barney S. Graham   IMMUNOLOGICAL REVIEWS

Therapeutic targeting of respiratory syncytial virus G-protein

(2010) Lawrence M Kauvar et al.   Immunotherapy

Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naive and Formalin-Inactivated RSV-Immunized BALB/c Mice

(2010) G. U. Radu et al.   JOURNAL OF VIROLOGY

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

(2010) Harish Nair et al.   LANCET

CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung

(2010) Cyrille Mionnet et al.   NATURE MEDICINE

Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice

(2009) C. Miao et al.   JOURNAL OF GENERAL VIROLOGY

Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients

(2009) E. J. Collarini et al.   JOURNAL OF IMMUNOLOGY

Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice

(2009) Lia M. Haynes et al.   JOURNAL OF INFECTIOUS DISEASES

Monocyte Chemoattractant Protein-1 (MCP-1): An Overview

(2009) Satish L. Deshmane et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

A Chimeric A2 Strain of Respiratory Syncytial Virus (RSV) with the Fusion Protein of RSV Strain Line 19 Exhibits Enhanced Viral Load, Mucus, and Airway Dysfunction

(2009) M. L. Moore et al.   JOURNAL OF VIROLOGY

The Burden of Respiratory Syncytial Virus Infection in Young Children

(2009) Caroline Breese Hall et al.   NEW ENGLAND JOURNAL OF MEDICINE

Respiratory Syncytial Virus Proteins Modulate Suppressors of Cytokine Signaling 1 and 3 and the Type I Interferon Response to Infection by a Toll-Like Receptor Pathway

(2009) Christine M. Oshansky et al.   VIRAL IMMUNOLOGY

Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-γ axis

(2008) J. Bortolatto et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction

(2008) M. Shingai et al.   INTERNATIONAL IMMUNOLOGY

The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen Decoy and through Effects on Fc Receptor-Bearing Leukocytes

(2008) A. Bukreyev et al.   JOURNAL OF VIROLOGY

The RSV F and G glycoproteins interact to form a complex on the surface of infected cells

(2007) Kit-Wei Low et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS